Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Short-term management of insomnia Age: Adult |
Dose: Oral – 7.5-30 mg Frequency: at bedtime Duration: for 7-10 days Note: Maximum: 40 mg |
|
Indication: Short-term management of insomnia Age: Elderly |
Dose: Oral – 5 mg Frequency: at bedtime Note: May be increased to 10-20 mg in severe cases |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Insomnia Condition: Renal impairment |
Dose: Tablet – 5 mg Frequency: at bedtime |
|
Indication: Insomnia Condition: Severe renal impairment |
Dose: Tablet – 10-20 mg Frequency: at bedtime |
Administration
- Can be taken with or without food
- Take at bedtime
Side Effect
- Drowsiness (9.1%)
- Dizziness (4.5%)
- Lethargy (4.5%)
- Hangover (2.5%)
- Diarrhea (1.7%)
- Euphoria (1.5%)
- Weakness (1.4%)
- Confusion (1.3%)
- Vertigo (1.2%)
- Amnesia
- Angioedema
- Blood dyscrasias
- Sleep-related behavior (eg sleep driving, sleep cooking, sleep eating)
- Ataxia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Na oxybate, Antipsychotics (Haloperidol, Risperidone, Quetiapine, Olanzapine, Clozapine, Aripiprazole), Tranquilisers, Neuroleptics, Antidepressants (Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram, Venlafaxine, Duloxetine), Hypnotics, Anaesthetics, Analgesics, Sedative Antihistamines (Diphenhydramine, Loratadine, Levocetirizine, Cetirizine, Fexofenadine, Hydroxyzine, Bilastin), Barbiturates
|
May enhance CNS depressant effect
|
|
Theophylline
|
Effect may be reduced
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Acute Pulmonary Insufficiency/Sleep Apnea
|
Can cause breathing problems
|
|
Myasthenia Gravis
|
Can worsen muscle weakness
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store temazepam at room temperature, 20° to 25°C. Keep temazepam and all medicines out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.